IGF-binding protein-derived peptide or small molecule

Details for Australian Patent Application No. 2002324672 (hide)

Owner Bioexpertise, LLC

Inventors Mascarenhas, Desmond

Agent Davies Collison Cave

Pub. Number AU-B-2002324672

PCT Number PCT/US02/25532

PCT Pub. Number WO2003/025121

Priority 60/323,267 18.09.01 US

Filing date 9 August 2002

Wipo publication date 1 April 2003

Acceptance publication date 8 November 2007

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 31/7008 (2006.01) - Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine

A61K 31/704 (2006.01)

A61K 31/7048 (2006.01)

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

A61K 38/30 (2006.01) Medicinal preparations containing peptides - Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/47 Peptides having more than 20 amino acids

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/323,267 18.09.01 US

5 June 2003 Application Open to Public Inspection

  Published as AU-B-2002324672

8 November 2007 Application Accepted

  Published as AU-B-2002324672

6 March 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002324673-SYSTEMS AND METHODS FOR USE IN ELECTRONIC PROCESSING OF FOREIGN ORIGIN AND EXPORT SHIPMENTS AND/OR PASSENGERS AND BAGGAGE AT SECURITY CHECK POINTS

2002324671-Computer system partitioning using data transfer routing mechanism